Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Longitudinal associations of cardiovascular health and vascular events with incident dementia.

Stroke and vascular neurology·2023
Same author

Cerebral Small Vessel Disease Is Associated with Motor, Cognitive, and Emotional Dysfunction in Multiple System Atrophy.

Journal of Parkinson's disease·2023
Same author

Inflammation and Brain Structure in Alzheimer's Disease and Other Neurodegenerative Disorders: a Mendelian Randomization Study.

Molecular neurobiology·2023
Same author

Association of biological age with health outcomes and its modifiable factors.

Aging cell·2023
Same author

The causal role of circulating amino acids on neurodegenerative disorders: A two-sample Mendelian randomization study.

Journal of neurochemistry·2023
Same author

TMEM106B aggregation in neurodegenerative diseases: linking genetics to function.

Molecular neurodegeneration·2023
Same journal

Evidence for progressive neurodegeneration in iatrogenic cerebral amyloid angiopathy.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Human brain connectome profiles mediate the relationship between pathology burden and clinical phenotypes in Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Kat5 cKO mouse replicates biological domain signatures associated with Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Evaluation of CSF and plasma tau species as fluid surrogate candidates for tau PET in prodromal to moderate Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Associations of self-reported obstructive sleep apnea with cognition and dementia risk in cognitively unimpaired middle-aged adults.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Inflammation profiles in Alzheimer's disease relate to cognition and neurodegeneration.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
查看所有相关文章

相关实验视频

Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K

生物标志物 生物标志物

Xiao-Yu He1, Jin-Tai Yu2

  • 1Huashan Hospital, Fudan University, Shanghai, China.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
PubMed
概括
此摘要是机器生成的。

这项研究揭示了痴呆症发病前几年的动态多基因变化,确定了关键生物标志物和早期干预的潜在药物标. 先进的机器学习使用集成的omics数据改善了痴呆症风险预测.

更多相关视频

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

相关实验视频

Last Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

科学领域:

  • 基因组学就是基因组学.
  • 蛋白质组学是指蛋白质组学.
  • 代谢学 代谢学 代谢学
  • 神经科学是一个神经科学.
  • 生物标志物发现发现

背景情况:

  • 痴呆症是导致残疾的主要原因,具有重大社会经济影响.
  • 了解分子机制和识别早期生物标志物对于有效的痴呆症干预至关重要.
  • 多学科方法为研究痴呆症病原体提供了一个全面的框架.

研究的目的:

  • 进行纵向的多学科分析,揭开痴呆症的复杂分子基础.
  • 识别与痴呆相关的遗传变异,蛋白质和代谢物.
  • 开发先进的机器学习模型,以改善痴呆风险预测,并确定潜在的治疗目标.

主要方法:

  • 纵向多基因组分析整合了来自大型队列的全基因组测序,蛋白质组学,代谢学和临床数据 (N=320,226).
  • 单个学科的关联分析,然后使用机器学习进行跨学科的整合.
  • 调解分析和门德尔的随机化评估因果关系和确定药物点.

主要成果:

  • 确定了203个主要遗传变异和228个与痴呆症亚型相关的候选基因.
  • 揭示了不同的生物模块,包括脂质代谢失调和突触功能障碍.
  • 在诊断前长达15年的血液多奥米克特征中显示出动态变化,特定的蛋白质和代谢物显示出早期升高.
  • 一个FT-Transformer模型通过整合多omics数据显著改善了痴呆风险预测.
  • 确定了258个介质,包括GDF15,IGFBP2和NEFL,以及24个潜在的药物标,其中8个具有现有药物.

结论:

  • 为了解痴呆症分子机制,建立了一个全面的多学科框架.
  • 突出了痴呆症发病前多omics个人资料的动态演变,为早期干预提供了途径.
  • 确定了预测性生物标志物和潜在的治疗点,包括新的点和药物重新用途的机会.